Aster DM Result Second Quarter 2018

Aster DM

Performance Review for Q2FY19 vs. Q2FY18
 Revenue from operations improves by 17% to Rs. 1,837 crore compared to Rs. 1,566 crore.
 EBITDA (excluding other income) reduces by 9% Y-o-Y to Rs. 125 crore compared to Rs. 138 crore.
 PAT increases to Rs. 11 crore compared to Rs. 0.51 crore.
 Diluted Earnings Per Share up to Rs. 0.22 as compared to Rs. 0.01.

Performance Review for H1FY19 vs. H1FY18
 Revenue from operations improves by 16% to Rs. 3,612 crore compared to Rs. 3,123 crore.
 EBITDA (excluding other income) grew by 40% Y-o-Y to Rs. 249 crore compared to Rs. 178 crore.
 PAT increases to Rs. 23 crore compared to loss of Rs. 76 crore.
 Diluted Earnings Per Share up to Rs. 0.47 as compared to loss of Rs. 1.65.

About Aster DM Healthcare
Aster DM Healthcare Limited is one of the largest private healthcare service providers operating in multiple GCC states and is an emerging healthcare player in India. With an inherent emphasis on clinical excellence the Company is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare through its 21 hospitals, 113 clinics and 216 pharmacies. These are manned by our 17,700+ employees from across the geographies that we are present in, delivering on a simple yet strong promise to its people: “We’ll treat you well.” We reach out to all economic segments in the GCC states through our differentiated healthcare services across the “Aster”, “Medcare” and “Access” brands.